In this video, Yasha S. Modi, MD, discusses end-of-study results for EYP-1901 from EyePoint Pharmaceuticals, a bioerodible, sustained-release intravitreal insert to deliver vorolanib for diabetic ...

More than half of adults and more than one-third of children living in the same home as another adult with prediabetes have ...

Neighborhoods with high vs. moderate and low social vulnerability had the greatest rise in asthma-related ED visits between ...

The American Academy of Orthopaedic Surgeons and the Musculoskeletal Tumor Society have developed a registry that aims to ...

At this year’s AIMed25 conference, attendees will learn more about the future of AI in health care from industry leaders, ...

Daily physical activity is effective in reducing risk for heart disease, but a dogmatic 10,000 steps per day goal is not ...

When I attended Franklin & Marshall College in Lancaster, Pennsylvania, I was pre-med mainly for the fun of getting to say, ...

The FDA has started reporting real-time data about adverse events through the FDA Adverse Event Reporting System, improving ...

Wearing orthokeratology contact lenses for 11 years led to a substantial reduction in axial length, with a mean treatment ...

NCX 470 0.1%, a novel nitric oxide-donating bimatoprost eye drop, achieved its primary endpoint in the phase 3 Denali ...

Patients who start dialysis with Medicare Advantage have an 18% lower likelihood of being wait-listed for a kidney transplant ...

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...